In the highly regulated pharmaceutical industry, even seemingly minor details can have major compliance implications — and flooring is no exception. For manufacturers operating to Good Manufacturing Practice (GMP) and ISO 14644 standards, the choice of flooring can directly influence hygiene, safety, and audit performance.

Abacus Flooring Solutions, a UK-based specialist in industrial resin systems, has established a strong presence in the pharmaceutical sector by delivering bespoke flooring designed for sterile environments. From ISO-classified cleanrooms to high-traffic packaging zones, the company’s seamless, non-porous resin surfaces are engineered to resist bacterial growth, chemical damage, and particle contamination.

The flooring systems are also designed to withstand the demanding conditions of pharmaceutical manufacturing, including thermal shock from steam cleaning, chemical exposure from alcohol-based sanitisers and corrosive disinfectants, and heavy traffic from trolleys, forklifts, and footfall. Anti-slip (R10–R13) and electrostatic discharge (ESD) options are available, along with colour-coded zoning for workflow control.

Sustainability is another focus. Abacus’s Abaplas™ system incorporates 100% recycled plastic aggregate, reducing landfill waste and lowering the carbon footprint of installations, while maintaining full compatibility with GMP and ISO standards. All work is carried out by in-house trained teams, ensuring quality control and minimal disruption — with some projects completed in as little as 24–48 hours.

Abacus Flooring Solutions has delivered resin flooring for a number of leading pharmaceutical manufacturers, including Reckitt, supporting production facilities in maintaining compliance and minimising downtime during refurbishments.